Skip to main content
S&P 5007,801.77-0.22%DOW51,179.87-0.66%NASDAQ27,538.69-0.22%BTC$83,121.00-2.90%ETH$2,566.72-4.85%GOLD$4,136.70-0.10%OIL$88.94+0.75%
Smart Investors Daily
SID Premium
MD

NASDAQ · MDAI

Spectral AI, Inc.

Healthcare · Medical - Devices

$1.66

Down-$0.02 (-1.20%)

Updated Oct 7, 2026, 10:00 PM

SID Score

5.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
52.94M
P/E ratio
-3.06
Dividend yield
0.00%
52-week range
$1.18 – $2.97
Volume
262.91K
Avg. volume
592.78K

Price performance · MDAI

MDAI price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

MDAI closed at $1.66 after 21 trading sessions, up 3.11% for the selected period.

Last close
$1.66
Period change
+3.11%
Period low
$1.55
Period high
$1.69
Daily close
View OHLC price history
MDAI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$1.67$1.805$1.66$1.66262.91K
Oct 5, 2026$1.67$1.69$1.6501$1.69132.44K
Oct 2, 2026$1.67$1.67$1.63$1.66188.02K
Oct 1, 2026$1.66$1.67$1.6209$1.6670.23K
Sep 30, 2026$1.60$1.68$1.575$1.66144.47K
Sep 29, 2026$1.62$1.62$1.57$1.5879.55K
Sep 28, 2026$1.59$1.65$1.59$1.61121.65K
Sep 25, 2026$1.60$1.635$1.584$1.5982.67K
Sep 24, 2026$1.65$1.69$1.6016$1.6297.91K
Sep 23, 2026$1.65$1.69$1.65$1.66195.43K
Sep 22, 2026$1.66$1.69$1.64$1.6691.64K
Sep 21, 2026$1.64$1.71$1.63$1.66186.54K
Sep 18, 2026$1.62$1.6451$1.605$1.64220.94K
Sep 17, 2026$1.57$1.615$1.56$1.59117.37K
Sep 16, 2026$1.59$1.59$1.55$1.55100.52K
Sep 15, 2026$1.59$1.63$1.58$1.5980.9K
Sep 14, 2026$1.58$1.63$1.58$1.61128.35K
Sep 11, 2026$1.57$1.62$1.57$1.60116.9K
Sep 10, 2026$1.57$1.60$1.54$1.56138.58K
Sep 9, 2026$1.61$1.63$1.57$1.5882.5K
Sep 8, 2026$1.61$1.67$1.5807$1.61193.44K

Latest MDAI news

The latest Smart Investors Daily articles mentioning MDAI.

Stock researchCompany · Overview

MDAI research

Overview

Company profile and research snapshot.

Company profile

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.50
Implied upside
—
Analysts
—
MDAI recent ratings
DateFirmRatingTarget
May 27, 2026BTIGBuy—
May 26, 2026BTIGBuy—
Mar 25, 2026BTIGBuy—
Feb 10, 2026BTIGBuy—
Nov 12, 2025BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet

DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of the first Site Initiation Visit (“SIV”) associated with the commencement of a clinical study designed to support a label expansion of the Company’s FDA-cleared DeepView System™ for Burn Indication to include burns involvin

Yahoo · Sep 24, 2026

Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds

DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a scheduled presentation at the upcoming ACS Clinical Congress 2026, being held September 26-29, 2026 in Washington, DC. Entitled “Artificial Intelligence Training & Validation of Multi-Spectral Imaging Device for Evaluation of Burn Wounds

Yahoo · Sep 16, 2026

Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference

Announces Upcoming Burn Conference ScheduleDALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the Southern Regional Burn Conference (SRBC), held September 10-12, 2026 in Williamsburg, Virginia. The Company’s DeepView® System for Burn Indication was on dis

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By